China Jo-Jo Drugstores, Inc.
CJJD · NASDAQ
9/30/2024 | 3/31/2024 | 9/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Revenue | – | $75,967 | $78,574 | $76,090 |
| % Growth | – | -3.3% | 3.3% | – |
| Cost of Goods Sold | – | $60,791 | $62,641 | $58,730 |
| Gross Profit | – | $15,175 | $15,933 | $17,360 |
| % Margin | – | 20% | 20.3% | 22.8% |
| R&D Expenses | – | $0 | $0 | $0 |
| G&A Expenses | – | $5,625 | $1,632 | $12,033 |
| SG&A Expenses | – | $18,966 | $15,677 | $37,040 |
| Sales & Mktg Exp. | – | $5,853 | $14,045 | $14,647 |
| Other Operating Expenses | – | $0 | $0 | $0 |
| Operating Expenses | – | $18,748 | $17,035 | $38,681 |
| Operating Income | – | -$3,791 | $256 | -$19,681 |
| % Margin | – | -5% | 0.3% | -25.9% |
| Other Income/Exp. Net | – | $504 | -$1,141 | -$907 |
| Pre-Tax Income | – | -$3,286 | -$885 | -$20,588 |
| Tax Expense | – | $24 | $39 | -$44 |
| Net Income | – | -$3,310 | -$924 | -$20,544 |
| % Margin | – | -4.4% | -1.2% | -27% |
| EPS | – | -1.96 | -0.78 | -25.9 |
| % Growth | – | -151.3% | 97% | – |
| EPS Diluted | – | -1.96 | -0.78 | -25.9 |
| Weighted Avg Shares Out | – | 1,692 | 1,196 | 793 |
| Weighted Avg Shares Out Dil | – | 1,693 | 1,196 | 793 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | $443 | $0 | $733 |
| Interest Expense | – | $13 | $0 | $0 |
| Depreciation & Amortization | – | $451 | $321 | $68 |
| EBITDA | – | -$3,074 | $577 | -$19,613 |
| % Margin | – | -4% | 0.7% | -25.8% |